In today’s fast-paced digital landscape, businesses face a critical challenge: balancing efficiency with innovation. While off-the-shelf software once seemed convenient, companies increasingly realize ...

As Lady Bracknell almost said, ‘to lose one may be regarded as a misfortune; to lose two looks like carelessness.’ And so a second Government Statistician has made a hasty exit, The official reason in ...

Generic secrets are hard to detect and are getting leaked more often. See how GitGuardian offers advanced protection where ...

The increasing costs and complexity of R&D in the pharmaceutical industry have necessitated the adoption of strategic ...

Eli Lilly launches anti-obesity and diabetes drug Mounjaro in India, priced competitively at Rs 14,000-17,500, a fraction of ...

Sixty-one education and communication projects were honored March 11 at Pensions & Investments ' 2025 Eddy Awards ceremony ...

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.

StockNews.com upgraded shares of Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) from a hold rating to a buy rating ...

Artificial Intelligence can help contractors develop better subcontractor relationships and streamline certificate of ...

InterCapital Asset Management (ICAM), the largest independent investment manager in Croatia, listed its second ETF (Exchange Traded Fund), tracking Slovenia’s main stock market index.  The ETF’s full ...

Corona Remedies introduces affordable generic version of empagliflozin for type 2 diabetes: Our Bureau, Mumbai Thursday, March 13, 2025, 17:50 Hrs [IST] Corona Remedies Limited ha ...